Fluticasone
Fluticasone is a pharmaceutical drug with 49 clinical trials. Currently 2 active trials ongoing. Historical success rate of 87.8%.
Success Metrics
Based on 36 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
9
Mid Stage
24
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
36 of 44 finished
18.2%
8 ended early
2
trials recruiting
49
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
ACTIV-6: COVID-19 Study of Repurposed Medications
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
New Serological Markers for Eosinophilic Esophagitis
Clinical Trials (49)
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
ACTIV-6: COVID-19 Study of Repurposed Medications
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
New Serological Markers for Eosinophilic Esophagitis
Elocon vs Fluticasone in Localized Psoriasis (P03197)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays
Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis
Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone
Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma
Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma
EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone
Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma
Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis
Repeated High-dose Inhaled Corticosteroids for Asthma
The Effect of Salmeterol on Eosinophil (EOS) Function
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 49